Show simple item record

dc.contributor.authorMorrison, Joanne
dc.date.accessioned2020-04-27T17:06:00Z
dc.date.available2020-04-27T17:06:00Z
dc.date.issued2020-04-23
dc.identifier.urihttp://hdl.handle.net/10713/12634
dc.descriptionNews release announcing the UMB School of Medicine's participation in an NIAID/NIH-sponsored clinical trial of remdesivir as a possible treatment for COVID-19. The research is being conducted through UMSOM’s Center for Vaccine Development and Global Health (CVD) and the Vaccine and Treatment Evaluation Unit (VTEU).en_US
dc.language.isoen_USen_US
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subjectremdesiviren_US
dc.subjectUniversity of Maryland, Baltimore. Center for Vaccine Development and Global Health (CVD)en_US
dc.subject.lcshUniversity of Maryland, Baltimore. School of Medicineen_US
dc.subject.lcshCOVID-19 (Disease)en_US
dc.subject.meshCOVID-19en_US
dc.titleUM School of Medicine Researchers Test Remdesivir as Potential Therapy for COVID-19 Patientsen_US
dc.typeArticleen_US
refterms.dateFOA2020-04-27T17:06:01Z


Files in this item

Thumbnail
Name:
SOMTestRemdesivir_2020.04.23.pdf
Size:
1.161Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record